The associated article is a meta-analysis reviewing published studies for SBRT for HCC with 5+ years of outcome data. 19 studies were identified that met the criteria. The article reviews those 19 studies and makes recommendations for appropriate SBRT for HCC.
The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.
This session highlights the most clinically relevant abstracts within the Breast Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Adaptive radiotherapy is emerging as a treatment approach for patients with improvements in technology that allow real-time planning and consequent treatment delivery. Different imaging modalities are used, such as MR and CBCT, for image guidance.